Skip to main content

Table 1 Baseline characteristics of BRCA1/2 mutation carriers and non-carriers according to the training and testing datasets

From: Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

 

Training dataset (n = 177)

Testing dataset (n = 60)

  

Variable

Non-carriers (n = 70)

UnaffectedBRCA1/2carriers (n = 107)

P-value for mutation carriers versus non-carriers

Non-carriers (n = 30)

UnaffectedBRCA1/2carriers (n = 30)

P-value for mutation carriers versus non-carriers

P-value2

P-value3

 

Mean (SD)

Range

Mean (SD)

Range

P-value fromt-test

Mean (SD)

Range

Mean (SD)

Range

P-value fromt-test

P-value fromt-test

Age, years

48.8 (9.6)

25, 79

37.7 (8.5)

22, 55

<0.0001

47.2 (10.1)

25, 74

37.8 (8.9)

25, 55

0.0003

0.44

0.95

Body mass index1

26.2 (5.7)

18.0, 45.5

25.5 (5.4)

17.9, 48.2

0.41

27.3 (6.7)

18.3, 49.5

25.9 (5.9)

19.5, 40.0

0.37

0.38

0.74

Percent mammographic density, unadjusted

32.2 (15.2)

3.5, 76.3

37.6 (14.7)

2.8, 70.8

0.02 4

30.7 (14.7)

2.0, 53.7

35.5 (14.2)

4.8, 68.4

0.214

0.66

0.47

 

Number

% *

Number

% *

P -value from chi square 5

Number

% *

Number

% *

P -value from chi square 5

P -value from chi square 5

White, non-Hispanic

63

90.0

107

100.0

0.001

25

83.3

30

100.0

0.05

0.35

1.00

College graduate

52

74.3

83

77.6

0.62

21

70.0

22

73.3

0.77

0.66

0.63

Ever smoked

17

24.3

35

32.7

0.23

13

43.3

8

26.7

0.18

0.06

0.53

Age at menarche, years

    

0.78

    

0.87

0.96

0.40

<12

10

14.5

13

12.3

 

5

16.7

6

20.0

   

12 to 13

42

60.9

70

66.0

 

18

60.0

16

53.3

   

≥14

17

24.6

23

21.7

 

7

23.3

8

26.7

   

Missing

1

 

1

         

Parous

52

74.3

61

57.0

0.02

24

80.0

13

43.3

0.004

0.54

0.18

Age at first birth, years

    

0.09

    

0.02

0.27

0.62

<30

36

51.4

41

38.3

 

19

63.3

10

33.3

   

≥30 or nulliparous

34

48.6

66

61.7

 

11

36.7

20

66.7

   

Ever used oral contraceptives

51

72.9

96

89.7

0.004

24

80.0

26

86.7

0.49

0.45

0.64

Menopausal status

    

<0.0001

    

0.08

0.59

0.83

Premenopausal

44

64.7

60

56.1

 

16

57.1

19

63.3

   

Postmenopausal, natural

4

5.9

6

5.6

 

4

14.3

2

6.7

   

Postmenopausal, surgical

9

13.2

40

37.4

 

4

14.3

9

30.0

   

Postmenopausal, unknown

11

16.2

1

0.9

 

4

14.3

0

0.0

   

Missing

2

 

0

  

2

 

0

    

Menopausal hormone therapy

    

0.97

    

0.31

0.95

0.30

Never

48

68.6

74

69.2

 

20

66.7

25

83.3

   

Former

10

14.3

16

15.0

 

5

16.7

2

6.7

   

Current

12

17.1

17

15.9

 

5

16.7

3

10.0

   

Breast biopsy prior to enrollment

21

30.0

26

24.3

0.40

5

16.7

7

23.3

0.52

0.16

0.91

  1. *Missing values were excluded from percentage calculations. 1Weight (kg)/height2 (m2). 2P-value comparing non-carriers in the training set to those in the testing set. 3P-value comparing BRCA1/2 carriers in the training set to those in the testing set. 4As previously reported [14], age-adjustment attenuatated the mean differences in percent mammographic density between carriers and non-carriers (age-adjusted P-value: training dataset = 0.79; testing dataset = 0.87). 5P-value from chi square test or Fisher’s exact test when appropriate. P-values <0.05 are shown in bold font.